SEC 13F Intelligence

Ghost Tree Capital, LLC / TGTX

Ghost Tree Capital, LLC’s Tg Therapeutics Inc Position

Does Ghost Tree Capital, LLC own Tg Therapeutics Inc (TGTX)? Yes310.0K shares worth $7M (+2.19% of its 13F portfolio) as of Q3 2024, down from 500.0K shares the prior filed quarter.

Position Value
$7M
Q3 2024
Shares
310.0K
% of Portfolio
+2.19%
Quarters Held
14
currently held

Position History TGTX

Reported value by quarter
Q4 ’19: $699,000Q4 ’19Q1 ’20: $2MQ2 ’20: $12MQ2 ’20Q3 ’20: $5MQ4 ’20: $13MQ4 ’20Q1 ’21: $10MQ2 ’21: $7MQ2 ’21Q1 ’23: $17MQ2 ’23: $20MQ2 ’23Q3 ’23: $8MQ4 ’23: $4MQ4 ’23Q1 ’24: $13MQ2 ’24: $9MQ2 ’24Q3 ’24: $7Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q3 2024310.0K$7M+2.19%
Q2 2024500.0K$9M+2.79%
Q1 2024825.0K$13M+3.47%
Q4 2023250.0K$4M+1.40%
Q3 20231.00M$8M+2.75%
Q2 2023825.0K$20M+6.77%
Q1 20231.10M$17M+4.89%
Q2 2021180.0K$7M+1.92%
Q1 2021200.0K$10M+2.27%
Q4 2020250.0K$13M+2.90%
Q3 2020200.0K$5M+1.55%
Q2 2020600.0K$12M+3.08%
Q1 2020200.0K$2M+0.52%
Q4 201963.0K$699,000+0.13%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Ghost Tree Capital, LLC’s full portfolio or all institutional holders of TGTX.